| ADMET | Absorption, distribution, metabolism, excretion and toxicity |
| AKT | Protein kinase B |
| AS | Ankylosing spondylitis |
| CD | Crohn’s disease |
| cIAP1/2 | Cellular inhibitor of apoptosis protein 1 or 2 |
| DCs | Dendritic cells |
| DD | Death domain |
| FADD | Fas-associated protein with death domain |
| IBD | Inflammatory bowel disease |
| ICAM-1 | Intracellular adhesion molecule 1 |
| JIA | Juvenile idiopathic arthritis |
| LUBAC | Linear ubiquitin chain assembly complex |
| MAPKs | Mitogen-activated protein kinases |
| MLKL | Mixed-lineage kinase domain-like protein |
| MMP | Matrix metalloproteinases |
| NF-κB | Nuclear factor κB |
| NIU | Noninfectious uveitis |
| PEG | Polyethylene glycosylated |
| PMNs | Polymorphonuclear leukocytes |
| PS | Psoriasis |
| PsA | Psoriatic arthritis |
| RA | Rheumatoid arthritis |
| RIPK1/3 | Receptor-interacting serine/threonine-protein kinase 1 or 3 |
| sTNF-α | Soluble TNF-α |
| TACE | TNF-α-converting enzyme |
| Th1 | Type 1 helper T cells |
| Th17 | Type 17 helper T cells |
| TIMPs | Tissue inhibitor of metalloproteinases |
| tmTNF-α | Transmembrane TNF-α |
| TNF-α | Tumor necrosis factor alpha |
| TNFR1 | TNF receptor type 1 |
| TNFR2 | TNF receptor type 2 |
| TRADD | TNFR1-associated death domain |
| TRAF2/5 | TNFR-associated factor 2 or 5 |
| Treg | Regulatory T cells |
| UC | Ulcerative colitis |
| VACM-1 | Vascular cell adhesion molecule 1 |